| The microbiome in autoimmune diseases |
34 |
| NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis |
25 |
| Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence |
21 |
| Separation of plasma-derived exosomes into CD3((+)) and CD3((-)) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients |
21 |
| The role of the immune system in kidney disease |
19 |
| Mucosal vaccines and technology |
19 |
| Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis |
18 |
| Mechanisms of human FoxP3(+) T-reg cell development and function in health and disease |
18 |
| Genetics of immune-mediated inflammatory diseases |
16 |
| IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis |
16 |
| Identification of circular RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for rheumatoid arthritis |
16 |
| Methods to manufacture regulatory T cells for cell therapy |
15 |
| Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts |
15 |
| Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab |
15 |
| The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017 |
14 |
| The immunopathogenesis of fibrosis in systemic sclerosis |
13 |
| Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer |
13 |
| Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease? |
13 |
| Emerging viruses and current strategies for vaccine intervention |
13 |
| Is Behcet's disease a class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behcet's disease |
12 |
| Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells |
12 |
| Novel approaches for the design, delivery and administration of vaccine technologies |
12 |
| The role of FOXP3(+) regulatory T cells in human autoimmune and inflammatory diseases |
11 |
| H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome |
11 |
| Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period |
10 |
| Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjogren's syndrome |
10 |
| Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis |
10 |
| Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis |
10 |
| Blood immune cell biomarkers in lung cancer |
10 |
| Influence of maternal microbiota during pregnancy on infant immunity |
9 |
| Embryonic extracellular vesicles as informers to the immune cells at the maternal-fetal interface |
9 |
| Critical roles of regulatory B and T cells in helminth parasite-induced protection against allergic airway inflammation |
9 |
| Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4 |
9 |
| IL-27: a double agent in the IL-6 family |
9 |
| In-vitro effect of pembrolizumab on different T regulatory cell subsets |
9 |
| Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency |
9 |
| Defective RNA sensing by RIG-I in severe influenza virus infection |
9 |
| Effect of pembrolizumab on CD4(+)CD25(+), CD4(+)LAP(+) and CD4(+)TIM-3(+) T cell subsets |
8 |
| Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting |
8 |
| Self-dsDNA in the pathogenesis of systemic lupus erythematosus |
8 |
| Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease |
8 |
| Human lactoferrin attenuates the proinflammatory response of neonatal monocyte-derived macrophages |
8 |
| Behcet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects |
8 |
| Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma |
8 |
| Dendritic cells, T cells and their interaction in rheumatoid arthritis |
7 |
| Enterovirus infection and type 1 diabetes: unraveling the crime scene |
7 |
| Blood clotting and traumatic injury with shock mediates complement-dependent neutrophil priming for extracellular ROS, ROS-dependent organ injury and coagulopathy |
7 |
| Synergistic effect of interleukin-17 and tumour necrosis factor-alpha on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways |
7 |
| Effect of two recombinant Trichinella spiralis serine protease inhibitors on TNBS-induced experimental colitis of mice |
7 |
| The immune system and psychiatric disease: a basic science perspective |
7 |
